User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse




Journal Article

Cytomics in predictive medicine


Valet,  G. K.
Former Research Groups, Max Planck Institute of Biochemistry, Max Planck Society;

External Ressource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available

Valet, G. K., & Tarnok, A. (2003). Cytomics in predictive medicine. Cytometry Part B-Clinical Cytometry, 53B(1), 1-3.

Cite as: http://hdl.handle.net/11858/00-001M-0000-0010-6C03-9
Patient-specific, disease-course predictions with >95% or >99% accuracy during therapy would be highly valuable for everyday medicine. If these predictors were available, disease aggravation or progression, frequently accompanied by irreversible tissue damage or therapeutic side effects, could then potentially be avoided by early preventive therapy. The molecular analysis of heterogeneous cellular systems (cytomics) by cytometry in conjunction with pattern-oriented bioinformatic analysis of the multiparametric cytometric and other data provides a promising approach to individualized or personalized medical treatment or disease management. As a consequence, better patient care and new forms of inductive scientific hypothesis development based on the interpretation of predictive data patterns are at reach. (C) 2003 Wiley-Liss, Inc.